In ₹ Crore except Per Share Latest Annual | MEDICAMEQ FY26 | MEDICO FY26 | AAREYDRUGS FY26 | NECLIFE FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 41.83× | ◆ 22.15× | 68.34× | — | 45.25× -8% | |
| P/B | 1.49× | ◆ 0.00× | 1.80× | 0.40× | 0.40× +274% | |
| EV/EBITDA | 21.75× | 0.89× | 44.46× | ◆ -3.59× | 0.89× +2340% | |
| Market Cap | ₹410 Cr | ₹0.1 Cr | ₹270 Cr | ₹231 Cr | ₹231 Cr +77% | |
| Growth | ||||||
| Revenue CAGR 3Y | 11.97% | 13.69% | ◆ 96.26% | -81.73% | 13.69% -13% | |
| Revenue CAGR 5Y | — | — | — | -64.04% | -64.04% | |
| Net Income CAGR 3Y | -12.71% | 21.89% | ◆ 100.20% | — | 61.05% -121% | |
| Revenue YoY (latest Q) | 11.27% | ◆ 81.43% | -56.34% | -99.99% | -56.34% +120% | |
| Net Income YoY (latest Q) | 15.35% | 38.49% | -25.36% | ◆ 75.65% | 38.49% -60% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 9.90% | 8.25% | 1.52% | — | 4.88% +103% | |
| Net Income Margin | 4.95% | ◆ 6.35% | 0.84% | -3152.45% | 0.84% +489% | |
| Return on Common Equity | 3.50% | ◆ 17.38% | 2.64% | -50.30% | 2.64% +33% | |
| Return on Capital Employed | 4.35% | ◆ 18.39% | 2.84% | -10.25% | 2.84% +53% | |
| Return on Assets | 2.63% | ◆ 8.55% | 1.33% | -47.12% | 1.33% +98% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.17× | 0.25× | 0.33× | ◆ 0.00× | 0.25× -32% | |
| Interest Coverage | 3.54× | ◆ 7.71× | 0.86× | -1.69× | 0.86× +312% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹198 Cr | ₹206 Cr | ₹472 Cr | ₹0 Cr | ₹206 Cr -4% | |
| Net Income | ₹9.8 Cr | ₹13.1 Cr | ₹4 Cr | −₹293 Cr | ₹4 Cr +147% | |
| Total Assets | ₹372 Cr | ₹153 Cr | ₹297 Cr | ₹622 Cr | ₹297 Cr +25% | |
| EPS | ₹7.22 | ₹1.58 | ₹1.39 | ₹-13.4 | ₹1.39 +419% | |
| Book Value per Share | ₹203.17 | ₹26,774.83 | ₹52.86 | ₹29.97 | ₹52.86 +284% | |